Adults 12 to 18, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
BMI ChangePrimary· Change from baseline at 4 months and 9 months
The primary outcome variable was change in BMI (weight (kg) / height2 (m)) that was further calculated from the height and weight measured at school in the morning time. Height was measured to the nearest 0.1 cm using a stadiometer and weight was measured to the nearest 0.1 kg on a TANITA digital scale (TBF-410) with the subject wearing lightweight clothing and no shoes.
Mean change from baseline to 4 months
Group
Value
95% CI
Intervention Group
-0.14
-0.44 – 0.16
Control Group
0.42
0.12 – 0.73
Mean change from baseline to 9 months
Group
Value
95% CI
Intervention Group
-0.66
-1.06 – -0.25
Control Group
0.68
0.16 – 1.20
BMIz ChangeSecondary· Change from baseline at 4 months and 9 months
The BMIz was converted from the BMI values using WHO 2007 reference standards. A z-score of 0 is equal to the mean and is considered normal. Lower numbers indicate values lower than the mean and higher numbers indicate values higher than the mean. Higher values denote a higher BMI.
Mean change from baseline to 4
Group
Value
95% CI
Intervention Group
-0.06
-0.12 – -0.00
Control Group
0.07
-0.00 – 0.14
Mean change from baseline to 9
Group
Value
95% CI
Intervention Group
-0.23
-0.32 – -0.14
Control Group
0.10
-0.03 – 0.22
Weight ChangeSecondary· Change from baseline at 4 months and 9 months
Weight was measured to the nearest 0.1 kg on a calibrated TANITA digital scale (TBF-410) with the subject wearing lightweight clothing and no shoes.
Mean change from baseline to 4
Group
Value
95% CI
Intervention Group
0.42
-0.28 – 1.12
Control Group
1.79
0.90 – 2.68
Mean change from baseline to 9
Group
Value
95% CI
Intervention Group
-0.15
-1.06 – 0.75
Control Group
2.76
1.45 – 4.07
Percent Body Fat ChangeSecondary· Change from baseline at 4 months and 9 months
Percent body fat was measured with the TANITA digital scale (TBF-410) using foot-to-foot bioelectrical impedance analysis.
Mean change from baseline to 4
Group
Value
95% CI
Intervention Group
-0.19
-1.18 – 0.80
Control Group
0.80
-0.24 – 1.84
Mean change from baseline to 9
Group
Value
95% CI
Intervention Group
-1.46
-2.41 – -0.52
Control Group
0.24
-0.60 – 1.07
Waist Circumference ChangeSecondary· Change from baseline at 4 months and 9 months
Waist circumference (cm) was measured with a flexible meter ribbon accurate to 0.1 cm at the midway between the lowest rib margin and the top of the iliac crest at the end of gentle expiration
Mean change from baseline to 4
Group
Value
95% CI
Intervention Group
-1.66
-3.02 – -0.29
Control Group
1.50
-0.01 – 3.01
Mean change from baseline to 9
Group
Value
95% CI
Intervention Group
-2.02
-3.80 – -0.23
Control Group
1.76
-0.25 – 3.77
Waist-to-height Ratio ChangeSecondary· Change from baseline at 4 months and 9 months
Waist-to-height ratio was calculated by dividing the waist circumference by the height.
Mean change from baseline to 4
Group
Value
95% CI
Intervention Group
-0.01
-0.02 – -0.00
Control Group
0.01
-0.00 – 0.02
Mean change from baseline to 9
Group
Value
95% CI
Intervention Group
-0.02
-0.03 – -0.01
Control Group
0.01
-0.01 – 0.02
Sponsor's own description
Considering that children with intellectual disability (ID) might be more vulnerable to obesity than their counterparts in the general population. This study aimed to develop and evaluate the effectiveness of an adapted physical activity (APA) program in reducing weight among adolescents with ID. The hypothesis of the study was the APA program would be able to decrease obesity among adolescents with ID.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT05082324 — Evaluation of Modification in VO2 Max After Performing the "Physical Activity and Health Course (PAPS) 53" Program
· NA
· unknown
NCT04735146 — Adapted Physical Activity to Promote Quality of Life, Well-being and Physical Activity Levels in Pregnant Women (WELL-DO
· NA
· unknown
NCT03866018 — Contribution of Physical Activity to Self-esteem and Motivation in Older Adults With Minor to Major Cognitive Disorders
· NA
· unknown
NCT03337412 — Adapted Physical Activity Study
· NA
· completed
NCT03169075 — QUALIOR Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program
· NA
· active not recruiting
Other recruiting trials for Obesity
Currently open trials in the same condition.
NCT07403604 — Effect of Insulin Lowering on Lipogenesis
· Phase 1
· recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee
· Phase 3
· recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass
· recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart
· Phase 3
· recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl
· Phase 1
· recruiting
Other Hong Kong Baptist University trials
Trials by the same sponsor.
NCT07469423 — Continuous Music and Sports Training for Children
· NA
· not yet recruiting
NCT07411456 — School-based Active Play Intervention to Facilitate Movement Behaviours and Fundamental Movement Skills in Primary Schoo
· NA
· not yet recruiting
NCT07243223 — Urinary Incontinence in Older Hong Kong Women: A Cross-sectional Study
· not yet recruiting
NCT07056179 — Brief Behavioral Intervention to Maintain Sleep Regularity in Young Adults Over the Christmas Break
· NA
· not yet recruiting
NCT06741878 — A Biopsychosocial Approach to Improving Multidimensional Frailty Status in Community-Dwelling Older Adults
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hong Kong Baptist University
Last refreshed: 9 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04463069.